Published in Drug Week, October 16th, 2009
"with moderate facial acne vulgaris.(rated 3 on the 5-point investigator global assessment of acne severity scale) were recruited and randomized to receive once-daily...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.